[18F]F-RESCA-T4 is named as a drug or biological intervention in 2 clinical trials in our China trial register, 2 of which are recruiting. The lead sponsor is RenJi Hospital. Registered phases: Not applicable and Phase 2/3. Conditions studied include Lung Cancer; Lung Diseases; Lung Neoplasms.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06851663 | Trop2-targeted immunoPET Imaging of Solid Tumors (ClinicalTrials.gov ↗) Solid Tumor, Solid Carcinoma, Uroepithelial Carcinoma |
Phase 2/3 | Recruiting |
| NCT07026110 | Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer (ClinicalTrials.gov ↗) Lung Cancer, Lung Diseases, Lung Neoplasms |
Not applicable | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Lung Cancer | 1 |
| Lung Diseases | 1 |
| Lung Neoplasms | 1 |
| Lung Cancer Metastatic | 1 |
| Solid Tumor | 1 |
| Solid Carcinoma | 1 |
| Uroepithelial Carcinoma | 1 |
| Bladder Cancer | 1 |
| Lead sponsor | Trials |
|---|---|
| RenJi Hospital | 2 |
| Register | [18F]F-RESCA-T4 trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how [18F]F-RESCA-T4 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists [18F]F-RESCA-T4 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.